In 2010, Industry, Particularly J&J, Faced GMP Challenges

摘要

In 2010, the drug industry faced numerous challenges to good manufacturing practice (GMP) compliance, including supplier issues, viral contaminations and unusual smelling drugs. But some companies, particularly Johnson & Johnson (J&J), grabbed more than their share of headlines in 2010.rnJ& J's manufacturing troubles actually kicked off in late 2009 with a recall of Children's Tylenol, followed quickly by an unas-sociated, limited recall of Tylenol Arthritis Pain caplets due to an "uncharacteristic smell or taste" with certain lots of the product.